Reason

Repair Biotechnologies is a preclinical-stage biotechnology company dedicated to developing therapies that target the fundamental causes of age-related diseases. Co-founded by the prominent longevity advocate known as Reason, the company is advancing a proprietary Cholesterol Degrading Platform (CDP) designed to reverse atherosclerosis by enabling macrophages to break down excess intracellular cholesterol. Additionally, the company is developing a gene therapy program focused on thymus regeneration through the upregulation of FOXN1 to restore immune function in older patients. Repair Biotechnologies aims to significantly extend human healthspan by repairing cellular and molecular damage associated with the aging process.